See more : Glen Rose Petroleum Corporation (GLRP) Income Statement Analysis – Financial Results
Complete financial analysis of PRED income statement, including revenue, profit margins, EPS and key performance metrics. Updated 2024.
- Rakuten Group, Inc. (RKUNY) Income Statement Analysis – Financial Results
- Guangdong Hoshion Aluminium Co., Ltd. (002824.SZ) Income Statement Analysis – Financial Results
- SMI Culture & Travel Group Holdings Limited (2366.HK) Income Statement Analysis – Financial Results
- Dcon Products Public Company Limited (DCON.BK) Income Statement Analysis – Financial Results
- Sunjin Co.,Ltd. (136490.KS) Income Statement Analysis – Financial Results
Predictive Technology Group, Inc. (PRED)
About Predictive Technology Group, Inc.
Predictive Technology Group, Inc., together with its subsidiaries, develops and commercializes discoveries and technologies involved in novel molecular diagnostic, therapeutic, and human cellular and tissue-based products (HCT/Ps). It operates in two segments, Human Cellular and Tissues Products (HCT/Ps); and Diagnostics and Therapeutics. The company provides FertilityDX, a genetic testing service for couples experiencing infertility; ARTguide, a genetic test for women experiencing infertility because of endometriosis and other genetic conditions; and regenerative medicine products, including AmnioCyte, AmnioCyte Plus, PolyCyte, and CoreCyte for use in regenerative medicine applications. It has a collaboration agreement with Atrin Pharmaceuticals LLC to develop molecular diagnostic tools to facilitate enhanced selection of cancer patients. The company was formerly known as Global Enterprises Group, Inc. and changed its name to Predictive Technology Group, Inc. in July 2015. Predictive Technology Group, Inc. was founded in 2005 and is headquartered in Salt Lake City, Utah.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2007 | 2006 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 24.44M | 43.49M | 16.62M | 2.59M | 75.27K | 0.00 | 0.00 |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 20.59M | 16.29M | 8.54M | 751.31K | 75.27K | 0.00 | 0.00 |
| Gross Profit | 0.00 | 0.00 | 0.00 | 3.86M | 27.20M | 8.08M | 1.83M | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 15.78% | 62.54% | 48.60% | 70.94% | 0.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 5.96M | 5.82M | 1.90M | 84.73K | 1.00K | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 24.47M | 18.23M | 5.83M | 946.75K | 1.39M | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 9.30M | 13.94M | 12.68M | 1.90M | 6.79K | 0.00 | 0.00 |
| SG&A | 0.00 | 0.00 | 0.00 | 33.76M | 32.17M | 18.51M | 2.84M | 1.39M | 0.00 | 0.00 |
| Other Expenses | 0.00 | 0.00 | 0.00 | 10.80M | 9.15M | 4.57M | 3.69M | 992.27K | 28.22K | 11.85K |
| Operating Expenses | 0.00 | 0.00 | 0.00 | 50.52M | 47.14M | 20.40M | 6.62M | 2.39M | 28.22K | 11.85K |
| Cost & Expenses | 0.00 | 0.00 | 0.00 | 71.10M | 63.43M | 28.95M | 7.37M | 2.46M | 28.22K | 11.85K |
| Interest Income | 0.00 | 0.00 | 0.00 | 596.09 | 17.50 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 0.00 | 0.00 | 596.09K | 358.51K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 167.90K | 228.49K | 236.56K | 11.54M | 9.15M | 4.57M | 3.69M | 992.27K | -126.00 | -224.00 |
| EBITDA | 0.00 | 0.00 | 0.00 | -84.42M | -11.47M | -7.82M | -1.09M | -1.40M | -28.34K | -12.08K |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% | -307.34% | -25.31% | -46.63% | 19.67% | 16,985.79% | 0.00% | 0.00% |
| Operating Income | 0.00 | 0.00 | 0.00 | -46.66M | -19.94M | -12.33M | -4.79M | -2.39M | -28.22K | -11.85K |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% | -190.92% | -45.85% | -74.14% | -185.22% | -3,171.94% | 0.00% | 0.00% |
| Total Other Income/Expenses | 0.00 | 0.00 | 0.00 | -39.85M | -841.32K | -700.00K | -1.42M | -14.24M | 0.00 | 0.00 |
| Income Before Tax | 0.00 | 0.00 | 0.00 | -96.56M | -20.78M | -13.03M | -6.20M | -16.63M | 0.00 | 0.00 |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | -395.06% | -47.78% | -78.35% | -240.00% | -22,092.63% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | 0.00 | 0.00 | -10.66M | -5.36M | -6.89M | -1.42M | -14.24M | 126.00 | 224.00 |
| Net Income | 0.00 | 0.00 | 0.00 | -85.90M | -15.42M | -6.07M | -6.17M | -16.60M | -28.34K | -12.08K |
| Net Income Ratio | 0.00% | 0.00% | 0.00% | -351.44% | -35.46% | -36.50% | -238.78% | -22,059.05% | 0.00% | 0.00% |
| EPS | 0.00 | 0.00 | 0.00 | -0.30 | -0.06 | -0.03 | -0.03 | -0.10 | -0.15 | -0.08 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | -0.30 | -0.06 | -0.03 | -0.03 | -0.10 | -0.15 | -0.08 |
| Weighted Avg Shares Out | 0.00 | 0.00 | 0.00 | 290.25M | 265.53M | 240.78M | 201.94M | 163.56M | 192.19K | 158.96K |
| Weighted Avg Shares Out (Dil) | 0.00 | 0.00 | 0.00 | 290.25M | 265.53M | 240.78M | 201.94M | 163.56M | 192.19K | 158.96K |
Source: https://incomestatements.info
Category: Stock Reports